Investor Presentation

Galenica Group

March 2024

Table of contents

About Galenica

page 03

Market environment

page 33

Business performance

page 43

Governance

page 66

Sustainability

page 77

Outlook

page 86

March 2024

Investor Presentation Galenica Group

2

About Galenica

Galenica in figures

Net sales

EBIT adjusted1

Galenica Group

Galenica Group

22%

CHF

35%

CHF

3,746.0

191.3

65% million

million

78%

Products & Care

Logistics & IT

Products & Care

Logistics & IT

1 Adjusted EBIT, excludes IAS 19 and IFRS 16 effects

Leading healthcare provider in Switzerland

369

own pharmacies

Employees (Headcount)

> 7,900

Dividend yield

3.0%

March 2024

Investor Presentation Galenica Group

4

Building the leading Swiss healthcare platform

IPO

Joint Venture

Creation of Amavita uniform

Opening of highly

brand in Switzerland

automated distribution

Acquisition

Acquisition

centre in Niederbipp

Umsatz

+10.2%

EBIT

2000

2002

2005

2007

2008

2009

2013

2017

+26.4%

Organic and

acquisition-led

Acquisition

Acquisition

Acquisition

expansion of

Acquisition

pharmacies

network

Segment Products & Care

Segment Logistics & IT

March 2024

Investor Presentation Galenica Group

5

Building the leading Swiss healthcare platform

Acquisition

Acquisition

Acquisition

Acquisition

Acquisition

Acquisition

Participation

2018

2019

2020

2021

2022

2023

2024

Relaunch

Joint Venture

Joint Venture

Acquisition

Acquisition

Participation

Strategic

partnership

Strategic

partnership

Segment Products & Care

Segment Logistics & IT

Acquisition

March 2024

Investor Presentation Galenica Group

6

Switzerland's leading

fully integrated healthcare provider

Largest network of

Wide range of

pharmacies in

services for patients

Switzerland with over

and professional

500 pharmacies,

service providers

online and offline

Well-known brands

Leading provider of

and products and

logistics and IT in the

exclusive licensed

healthcare sector

products from

business partners

Sun Store Apotheke

Mit neuem Ladenkonzept

March 2024

Investor Presentation Galenica Group

7

The Galenica story

Vision

Health and well-being are at the heart of what we do. They are the reason we give our best every day.

Values

We build trust. We show respect. Together we are stronger. We act as entrepreneurs. We participate with passion.

Customer promise

We support people at every stage of life on their journey towards health and well-being. With personal and expert advice and a unique range of products and services. Anytime and anywhere in Switzerland.

Strategic programmes

Omni-Channel

Care

Professionals

Efficiency

Transformation

March 2024

8

Business model

March 2024

Investor Presentation Galenica Group

9

Strategic programmes and ESG

Megatrends

Changing customer

needs

Digitalisation

Interconnectedness

Cost pressure

Omi-Channel programme

Best customer experience anytime and anywhere

  • Build the required digital infrastructure to more efficiently connect our offline and online channels
  • An interconnected infrastructure that integrates and coordinates both, the personal and digital touchpoints

Further development and networking of all

online and offline channels

  • Offline: constantly enlarge and optimise the pharmacy network
  • Online: improve our online shops and our offerings for patients at home

Expansion of product range

  • Expansion of product & service offerings according to our customer's expectations

ESG impact

Patient health, data protection

  • Customer satisfaction: more efficient and convenient health care improves wellbeing and health of our customers
  • Data protection as a prerequisite for digital services
  • Customer satisfaction: better health care services
  • Affordability of health care: Galenica supports substitution by generics

March 2024

Investor Presentation Galenica Group

10

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Galenica AG published this content on 11 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 March 2024 06:15:06 UTC.